FDA.reportPublic FDA data

sodium oxybate 6000 MG Granules for Oral Suspension

RxCUI
2636830
RxNorm name
sodium oxybate 6000 MG Granules for Oral Suspension
Display name
sodium oxybate 6000 MG Granules for Oral Suspension
Full name
sodium oxybate 6000 MG Granules for Oral Suspension
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LumryzSODIUM OXYBATEAvadel CNS Pharmaceuticals, LLC10e5e40c-52f3-4c73-8a34-2c29c690a9342025-12-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2636830

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
10e5e40c-52f3-4c73-8a34-2c29c690a934sodium oxybate 6000 MG Granules for Oral SuspensionSCD10These highlights do not include all the information needed to use LUMRYZ™ safely and effectively. See full prescribing information for LUMRYZ. LUMRYZ (sodium oxybate) for extended-release oral suspension, CIII Initial U.S. Approval: 200220251204
10e5e40c-52f3-4c73-8a34-2c29c690a934sodium oxybate 6 GM Granules for extended release Oral SuspensionPSN10These highlights do not include all the information needed to use LUMRYZ™ safely and effectively. See full prescribing information for LUMRYZ. LUMRYZ (sodium oxybate) for extended-release oral suspension, CIII Initial U.S. Approval: 200220251204
10e5e40c-52f3-4c73-8a34-2c29c690a934sodium oxybate 6 GM (equivalent to 5 GM oxybate) Granules for Oral SuspensionSY10These highlights do not include all the information needed to use LUMRYZ™ safely and effectively. See full prescribing information for LUMRYZ. LUMRYZ (sodium oxybate) for extended-release oral suspension, CIII Initial U.S. Approval: 200220251204